Selective biologics for ulcerative colitis and Crohn’s disease – clinical utility of vedolizumab

Inflammatory bowel disease (IBD) encompasses a cluster of different disease phenotypes which are broadly classified into ulcerative colitis and Crohn’s disease. Disease pathogenesis is driven by abnormal host immune responses to their resident gut microbiome in genetically susceptible individuals. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Petkau, Jill MV, Eksteen, Bertus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790488/
https://www.ncbi.nlm.nih.gov/pubmed/27022240
http://dx.doi.org/10.2147/BTT.S71679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790488/
https://www.ncbi.nlm.nih.gov/pubmed/27022240
http://dx.doi.org/10.2147/BTT.S71679

Ejemplares similares